News
That reputation is true as far as its goes. But, in spite of the emphasis on pure science, Yeda Research and Development, Weizmann’s technology transfer arm, has had great success in its efforts to ...
REHOVOT, Israel--(BUSINESS WIRE)--flō has signed an exclusive license agreement with Yeda Research and Development Co., Ltd. regarding the use of Weizmann Advanced Materials used for optical ...
About Yeda Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda currently manages approximately 500 unique patent families and has generated ...
An Israeli-Australian venture will use solar technology developed at the Weizmann Institute of Science ... license for the solar technology from Yeda, the Weizmann Institute's technology transfer ...
The program is being carried out in partnership with Yeda Research and Development Company, Weizmann's technology transfer arm. More information: Sabita Chourasia et al, MTCH2 controls energy ...
Yeda Research and Development Company, the Weizmann Institute’s technology transfer arm, has licensed the drug to Steba Biotech, which manufactures Tookad Soluble. Amir Naiberg, CEO of Yeda ...
Last year, Yeda Research and Development, the tech transfer office of the Weizmann Institute, sued ImClone and Sanofi-Aventis over the Erbitux patent. (The patent was owned by the latter and licensed ...
Abbott Laboratories will fund research programs in select areas of medicine through Yeda Research and Development Company, the technology transfer arm of the world-renowned Weizmann Institute of ...
Yeda’s Chief Business Officer ... Johnson will encourage the growth of novel directions in research at the Weizmann Institute and the development of new intellectual property.” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results